A detailed history of Coppell Advisory Solutions Corp. transactions in Pfizer Inc stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 13,275 shares of PFE stock, worth $349,929. This represents 0.07% of its overall portfolio holdings.

Number of Shares
13,275
Previous 9,602 38.25%
Holding current value
$349,929
Previous $388 Million 5.06%
% of portfolio
0.07%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $95,093 - $109,198
3,673 Added 38.25%
13,275 $368 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $297,197 - $386,907
7,545 Added 366.8%
9,602 $388 Million
Q4 2022

Feb 17, 2023

BUY
$41.75 - $54.5 $85,879 - $112,106
2,057 New
2,057 $105 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Coppell Advisory Solutions Corp. Portfolio

Follow Coppell Advisory Solutions Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.